NCT04311177
Losartan for Patients With COVID-19 Not Requiring Hospitalization
See it on ClinicalTrials.gov ↗117 people
49.6%
50.4%
58 womenmiddle line = equal numbers59 men
- Phase
- PHASE2
- Paid for by
- University of Minnesota
- Finished
- 2021-02-01
- Health conditions
- Corona Virus Infection, Acute Respiratory Distress Syndrome, SARS-CoV Infection
- Who could join
- Anyone
- Ages
- 18 Years – no maximum
- Average age
- Not reported
- Age 65+
- 2.6%
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- White 72.6% · Not reported 15.4% · Black / African American 6.8% · Asian 5.1% · American Indian / Alaska Native 0% · Native Hawaiian / Pacific Islander 0% · More than one race 0%
Women left out
- No pregnant women
Women who were pregnant could not join.
“Pregnant or breastfeeding women”
- No breastfeeding moms
Women who were breastfeeding could not join.
“Pregnant or breastfeeding women”
- No hormonal birth control
Women on the pill, patch, ring, shot, implant or hormonal IUD could not join.
“…ocol allowed version of contraception: intrauterine device, Depo-formulation of hormonal contraception (e.g. medroxyprogesterone acetate/Depo-Provera), subcutaneous contraceptive (e.g. Nexplanon), daily oral contraceptives with verbalized c…”
- No kidney or liver problems
Women with kidney or liver problems were turned away.
“Patient reported history or electronic medical record history of kidney disease, defined as:”
Study titles and rules are shown in their original English.